The National Disease Research Interchange (NDRI), a world leader in the procurement and distribution of biospecimens to advance research, has announced the promotion of Patrick Van Hoose, PhD, to the role of Director, NIH Initiatives. Dr. Van Hoose has served as Program Manager for the Developmental Genotype-Tissue Expression (dGTEx) initiative.

“We are proud to recognize Dr. Van Hoose’s excellent work leading the dGTEx initiative for NDRI,” said Bill Leinweber, President and CEO of NDRI. “His experience with NIH grants and understanding of the critical role of biospecimens in research will benefit our organization and our clients as he takes on these new responsibilities.”  

“I am excited to expand upon my work with our NIH research partners in this new role,” said Dr. Van Hoose. “This position will allow me to continue my work with dGTEx while also being involved with our ground-breaking Somatic Mosaicism across Human Tissues (SMaHT) program and other grant-funded programs.” 

In his new role, Dr. Van Hoose will be responsible for overseeing the day-to-day operations of the Biospecimen Procurement Center (BPC) for dGTEx and Tissue Procurement Center (TPC) for SMaHT, as well as working with program principal investigators on program planning and reporting to NIH.   

Dr. Van Hoose joined NDRI in 2022, after serving as a postdoctoral fellow with Children’s Hospital of Philadelphia and as postdoctoral research fellow at the University of Kentucky College of Medicine. He earned his PhD in Biochemistry and Molecular Biology from the University of Louisville.